Volume 4 - Issue 3

---

The emerging role of Calreticulin in cancer cells

WCRJ 2017; 4 (3): e926
DOI: 10.32113/wcrj_20179_926

Clinical experiences with temsirolimus in Glioblastoma multiforme; is it promising? A review of literature

WCRJ 2017; 4 (3): e923
DOI: 10.32113/wcrj_20179_923

Carcinogenic and therapeutic role of High-Mobility Group Box 1 in Cancer: is it a cancer facilitator, a cancer inhibitor or both?

WCRJ 2017; 4 (3): e919
DOI: 10.32113/wcrj_20179_919

Soft tissue sarcomas of the limbs: multidisciplinary treatment

WCRJ 2017; 4 (3): e917
DOI: 10.32113/wcrj_20179_917

Identification of known ABL Mutations by High Resolution Melt (HRM) Method as prevention of Imatinib-resistance

WCRJ 2017; 4 (3): e915
DOI: 10.32113/wcrj_20179_915

Cancer Incidence pattern in Iran Provinces and Association with Human Development Index

WCRJ 2017; 4 (3): e913
DOI: 10.32113/wcrj_20179_913

Lung cancer in the world: the incidence, mortality rate and risk factors

WCRJ 2017; 4 (3): e911
DOI: 10.32113/wcrj_20179_911

Causes of Death of Cancer Patients in a Referral Hospital In Northern Iran between 2013 and 2016

WCRJ 2017; 4 (3): e909
DOI: 10.32113/wcrj_20179_909